du Bois A - Search Results

1

Accelerating type-specific ovarian carcinoma research: Calculator for Ovarian Subtype Prediction (COSP) is a reliable high-throughput tool for case review.

Kommoss S, Gilks CB, Kommoss F, Chow C, Hilpert F, du Bois A, Köbel M, Huntsman DG, Anglesio M, Kalloger SE, Pfisterer J. Kommoss S, et al. Among authors: du bois a. Histopathology. 2013 Nov;63(5):704-12. doi: 10.1111/his.12219. Epub 2013 Sep 2. Histopathology. 2013. PMID: 24033430

2

Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron.

du Bois A, Meerpohl HG, Vach W, Kommoss FG, Fenzl E, Pfleiderer A. du Bois A, et al. Eur J Cancer. 1992;28(2-3):450-7. doi: 10.1016/s0959-8049(05)80075-9. Eur J Cancer. 1992. PMID: 1534250

3

Therapeutic strategies in cervical pregnancy.

Dall P, Pfisterer J, du Bois A, Wilhelm C, Pfleiderer A. Dall P, et al. Among authors: du bois a. Eur J Obstet Gynecol Reprod Biol. 1994 Sep;56(3):195-200. doi: 10.1016/0028-2243(94)90170-8. Eur J Obstet Gynecol Reprod Biol. 1994. PMID: 7821493 Review.

4

Cellular DNA content and survival in advanced ovarian carcinoma.

Pfisterer J, Kommoss F, Sauerbrei W, Renz H, du Bois A, Kiechle-Schwarz M, Pfleiderer A. Pfisterer J, et al. Among authors: du bois a. Cancer. 1994 Nov 1;74(9):2509-15. doi: 10.1002/1097-0142(19941101)74:9<2509::aid-cncr2820740919>3.0.co;2-f. Cancer. 1994. PMID: 7923008

5

Recurrent cytogenetic aberrations and loss of constitutional heterozygosity in ovarian carcinomas.

Kiechle-Schwarz M, Bauknecht T, Karck U, Kommoss F, du Bois A, Pfleiderer A. Kiechle-Schwarz M, et al. Among authors: du bois a. Gynecol Oncol. 1994 Nov;55(2):198-205. doi: 10.1006/gyno.1994.1277. Gynecol Oncol. 1994. PMID: 7959284

6

Transvaginal sonography of myometrial invasion depth in endometrial cancer.

Prömpeler HJ, Madjar H, du Bois A, Lattermann U, Wilhelm C, Kommoss F, Pfleiderer A. Prömpeler HJ, et al. Among authors: du bois a. Acta Obstet Gynecol Scand. 1994 Apr;73(4):343-6. doi: 10.3109/00016349409015776. Acta Obstet Gynecol Scand. 1994. PMID: 8160544

7

Phase II study of pirarubicin combined with cisplatin in recurrent ovarian cancer.

du Bois A, Meerpohl HG, Madjar H, Spinner D, Dall P, Pfisterer J, Bauknecht T. du Bois A, et al. J Cancer Res Clin Oncol. 1994;120(3):173-8. doi: 10.1007/BF01202198. J Cancer Res Clin Oncol. 1994. PMID: 8263015 Clinical Trial.

8

Paclitaxel-induced "recall" soft tissue ulcerations occurring at the site of previous subcutaneous administration of paclitaxel in low doses.

du Bois A, Kommoss FG, Pfisterer J, Lück HJ, Meerpohl HG. du Bois A, et al. Gynecol Oncol. 1996 Jan;60(1):94-6. doi: 10.1006/gyno.1996.0017. Gynecol Oncol. 1996. PMID: 8557235

9

[Anthracyclines in therapy of ovarian carcinoma: a systematic review of primary and 2nd-line therapy after platinum].

du Bois A, Lück HJ, Pfisterer J, Meier W, Bauknecht T. du Bois A, et al. Zentralbl Gynakol. 2000;122(5):255-67. Zentralbl Gynakol. 2000. PMID: 10857212 Review. German.

10

Co-cultivation of ovarian carcinoma cells with dermal fibroblasts induces fibroblast expression of sex steroid receptor transcripts and protein.

Kommoss F, Kiechle-Schwarz M, Dubois A, Pfisterer J, Spinner D, Madjar H, Bauknecht T, Pfleiderer A, Kacinski BM. Kommoss F, et al. Int J Gynecol Cancer. 1995 Mar;5(2):101-106. doi: 10.1046/j.1525-1438.1995.05020101.x. Int J Gynecol Cancer. 1995. PMID: 11578462

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

568 results

Search Page

Filters